Search

everythinglearnresearchcommunity

for

Search:↓

5% minoxidil foam is effective and safe for hair regrowth in women with hair loss.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

The treatment improved hair growth in people with male pattern baldness.

The treatment combination is effective and generally safe for lung cancer.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

CG2001 is safe and well-tolerated for treating hair loss in men.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

PRP and microneedling both effectively improve hair growth and thickness for treating hair loss.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Transplanting one's own hair follicle cells can improve hair loss in men and women, and is particularly effective in women.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Topical finasteride is an effective and safer treatment for male hair loss.

New anti-acne medications are being tested to offer alternatives to current treatments.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Hair regrowth improved, but quality of life did not.

New treatment with Wnt proteins and growth factors safely increases hair thickness.

Karunjchirakam Chooranam significantly improved symptoms in most PCOS cases.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.